Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations
Background The presence of deleterious mutations in breast cancer 1 gene (BRCA1) or
breast cancer 2 gene (BRCA2) significantly increases the risk of developing some cancers …
breast cancer 2 gene (BRCA2) significantly increases the risk of developing some cancers …
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
SL Coleridge, A Bryant, S Kehoe… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require surgery and chemotherapy for optimal treatment …
women. These women require surgery and chemotherapy for optimal treatment …
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Background The international standard of care for women with suspected advanced ovarian
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
Background Ovarian cancer is the seventh most common cancer among women and a
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …
Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer
SJ Chang, RE Bristow, HS Ryu - Annals of surgical oncology, 2012 - Springer
Background To analyze the impact of radical cytoreductive surgery—as part of primary tumor
debulking—on the amount of residual tumor and survival in patients with advanced ovarian …
debulking—on the amount of residual tumor and survival in patients with advanced ovarian …
Role of aggressive surgical cytoreduction in advanced ovarian cancer
SJ Chang, RE Bristow, DS Chi… - Journal of gynecologic …, 2015 - synapse.koreamed.org
Ovarian cancer is the eighth most frequent cancer in women and is the most lethal
gynecologic malignancy worldwide. The majority of ovarian cancer patients are newly …
gynecologic malignancy worldwide. The majority of ovarian cancer patients are newly …
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
J Morrison, K Haldar, S Kehoe… - Cochrane Database of …, 2012 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require surgery and chemotherapy for optimal treatment …
women. These women require surgery and chemotherapy for optimal treatment …
British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice
Epithelial ovarian cancer (EOC) is the 6th most common cancer among women in the UK
(2014) and accounts for 4% of all new cases of cancer in females: it has the highest mortality …
(2014) and accounts for 4% of all new cases of cancer in females: it has the highest mortality …
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer
SL Coleridge, A Bryant, S Kehoe… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require a combination of surgery and chemotherapy for optimal …
women. These women require a combination of surgery and chemotherapy for optimal …
Quality of life from cytoreductive surgery in advanced ovarian cancer: investigating the association between disease burden and surgical complexity in the …
Objective To investigate quality of life (QoL) and association with surgical complexity and
disease burden after surgical resection for advanced ovarian cancer in centres with variation …
disease burden after surgical resection for advanced ovarian cancer in centres with variation …